| Pharmaceutical active ingredients: |
| Cisplatin |
| Available forms, composition and doses of Citoplationo: |
| N / A |
| Citoplationo medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XA01 - Cisplatin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Citocor | Nikethamide | Unidentified Pharmaceutical Company |
| Citodorm | Methylpentynol | Unidentified Pharmaceutical Company |
| Citofen | Tamoxifen | Unidentified Pharmaceutical Company |
| Citopan | Hexobarbital | Unidentified Pharmaceutical Company |
| Citopcin | Ciprofloxacin | Unidentified Pharmaceutical Company |
| Citosarin | Cyclacillin | Unidentified Pharmaceutical Company |
| Citosulfan | Busulfan | Unidentified Pharmaceutical Company |
| Citra-Fort | Phenacetin | Unidentified Pharmaceutical Company |
| Citrene | Limonene | Unidentified Pharmaceutical Company |
| Citriscorb | Vitamin C | Unidentified Pharmaceutical Company |